Dexmedetomidine vs Propofol as an Adjunct to Ketamine for Electroconvulsive Therapy Anaesthesia

Yeter T., ONUR GÖNEN A., TÜRECİ E.

TURKISH JOURNAL OF ANAESTHESIOLOGY AND REANIMATION, vol.50, no.2, pp.114-120, 2022 (ESCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 50 Issue: 2
  • Publication Date: 2022
  • Doi Number: 10.5152/tjar.2021.21217
  • Journal Name: TURKISH JOURNAL OF ANAESTHESIOLOGY AND REANIMATION
  • Journal Indexes: Emerging Sources Citation Index (ESCI), Scopus, TR DİZİN (ULAKBİM)
  • Page Numbers: pp.114-120
  • Keywords: Dexmedetomidine, electroconvulsive therapy, ketamine, none-or anaesthesia, outpatient anaesthesia, propofol, PROCEDURAL SEDATION, HYPERDYNAMIC RESPONSES, SEIZURE THRESHOLD, ECT, KETAMINE/PROPOFOL, COMBINATION, DEPRESSION, MANAGEMENT, AGITATION, DURATION
  • Istanbul University Affiliated: No

Abstract

Objective: Electroconvulsive therapy is an effective non-pharmacological treatment for refractory mental illness, where a generalized seizure is induced under general anaesthesia. An ideal combination of the anaesthetic drugs should keep the patient paralyzed and unconscious for a few minutes, while allowing rapid recovery, supporting peri-procedural hemodynamic and respiratory stability, and permitting an effective treatment. We examined whether dexmedetomidine is advantageous over propofol as an adjunct to ketamine during electroconvulsive therapy.